A randomized, double-blind, parallel controlled phase I trial comparing the pharmacokinetics of recombinant humanized Monoclonal antibody against VEGF (JY028) injection with Anvertin in healthy subjects
Latest Information Update: 03 Dec 2020
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer; Wet age-related macular degeneration
- Focus Pharmacokinetics
Most Recent Events
- 03 Dec 2020 New trial record